Clinical Trial

Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 9, 2024 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis. The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care. This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.
Trial Details
NCT Number NCT06724627
Lead Sponsor BelleTorus Corporation
Collaborators: Urban Health Plan Inc.
Conditions Skin Condition, Dermatology, Dermatology/Skin - Other
Enrollment 263 participants
Start Date 2024-09-16
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-09